Clinical trials: Disruptive Behavior
ADHD
Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
Currently two different brands of modified-release formulations are providing 50% immediate release beads/pellets and 50% extended release beads/pellets, resulting in a rapid onset and dual peak concentrations of plasma…
- Trial name
- NCT00254878
- Testing
- Methylphenidate hydrochloride
- Where
- Germany
- Volunteers
- 130 people
- Sponsor
- Novartis
Specific Learning Disorder (MeSH Unique ID: D000067559), Dyslexia (MeSH Unique ID: D004410)
Reading Remediation and Outcomes in Detention
The current literature on academic skill difficulties, whether considered as part of the continuum of ability or as a specific learning disability (LD), indicates that these problems often coexist with conduct problems and…
- Conditions
- Specific Learning Disorder (MeSH Unique ID: D000067559), Dyslexia (MeSH Unique ID: D004410), Conduct Disorder (MeSH Unique ID: D019955)
- Trial name
- SERIOUS (NCT03261076)
- Testing
- Strategies Enhancing Reading in Older Underperf. Students
- Where
- United States
- Volunteers
- 192 people
- Sponsor
- Baylor College of Medicine
ADHD, Disruptive Behaviours
Biosignatures for the Development of Attention Deficit Hyperactivity Disorder
As an exploratory aim of this grant, we examined the extent to which a comprehensive psychosocial intervention conducted in the summer can improve young children with disruptive behavior challenges as it relates to their…
- Trial name
- AHEAD (NCT07381855)
- Testing
- Summer treatment program for children transitioning to and from kindergarten (STP-K)
- Volunteers
- 323 people, healthy volunteers welcome
- Sponsor
- Florida International University
Attention Deficit Hyperactivity Disorder
Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects
This clinical study is designed to evaluate the safety and tolerability of a single oral administration of a Metadoxine slow release formulation to subjects diagnosed as having ADHD.
- Trial name
- NCT00995085
- Testing
- Extended Release Metadoxine
- Where
- Israel
- Volunteers
- 43 people
- Sponsor
- Alcobra Ltd.
ADHD, Behavioral Addiction
Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of…
- Trial name
- ADHDDICT (NCT06797726)
- Testing
- Cognitive behavioral therapy
- Where
- 3 sites in France
- Volunteers
- 54 people
- Sponsor
- University Hospital, Tours
Attention Deficit Hyperactivity Disorder
A Bioequivalence (BE) Study in Healthy Subjects
To demonstrate the bioequivalence of 12.5 milliliters (mL) of atomoxetine oral solution (4 milligrams per milliliter [mg/mL]) compared with 2 capsules of atomoxetine (25 mg per capsule) in healthy adult male Japanese subjects.
- Trial name
- NCT01177943
- Testing
- Atomoxetine
- Where
- Japan
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Attention-Deficit Hyperactivity Disorder
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
To evaluate the sensitivity and responsiveness of a standardized, validated, computer-based, battery of neuro-psychometric tests in adults with ADHD.
- Trial name
- NCT01010750
- Testing
- Lisdexamfetamine Dimesylate (LDX), Immediate Release Mixed Amphetamine Salts (MAS-IR)
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Shire
Attention Deficit Disorder With Hyperactivity
An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the efficacy, tolerability and effects of Osmotic Release Oral System (OROS) methylphenidate hydrochloride (HCl) on learning skill changes in Korean participants with Attention-Deficit…
- Trial name
- NCT01060150
- Testing
- OROS Methylphenidate HCl
- Volunteers
- 115 people
- Sponsor
- Janssen Korea, Ltd., Korea
Implementation Research, Depressive Disorder
Pediatric Behavioral Health Integrated Care: Indiana Statewide Strategic Plan to Address the Growing Mental Health Crisis
This research is designed to analyze the implementation and fidelity of Pediatric Integrated Behavioral Health (PEDS-IBH). PEDS-IBH is a multifaceted project designed to address the pediatric mental health crisis by providing…
- Conditions
- Implementation Research, Depressive Disorder, ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Conduct Disorders in Children
- Trial name
- PEDS-IBH (NCT07216638)
- Where
- United States
- Volunteers
- 575 people
- Sponsor
- Indiana University
Attention Deficit Disorder
The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder
The purpose of this study is to show that Prepulse inhibition test of acoustic startle response is an indicator of objective diagnostic characteristics of attention deficit disorder in children and adolescents.
- Trial name
- PPI (NCT02344784)
- Testing
- SR-HLAB EMG, Methylphenidate
- Where
- Israel
- Volunteers
- 46 people
- Sponsor
- HaEmek Medical Center, Israel
ADHD
The Effects of ADHD Medication (TEAM) Study
This study evaluates the effects of receiving and then discontinuing methylphenidate (MPH) in children with ADHD. After receiving MPH for 8 weeks, participants will be randomized to either discontinue MPH (and receive placebo) OR…
- Trial name
- TEAM (NCT02293655)
- Testing
- OROS-Methylphenidate (MPH)
- Where
- 2 sites in United States
- Volunteers
- 204 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Disorder (ADD)
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
The purpose of this study is to investigate the efficacy of twenty daily sessions of home-based tDCS over the left DLPFC, right IFG on attention and response inhibition in children with ADHD.
- Trial name
- NCT04634006
- Testing
- Home-based transcranial direct current (tDCS) device
- Where
- Belgium
- Volunteers
- 75 people
- Sponsor
- Onze Lieve Vrouw Hospital
ADHD
School-Home Program for Mexican Children With Attention and Behavioral Concerns
A school-based behavioral intervention for Mexican youth with attention/behavior concerns (the Collaborative Life Skills Program for Latinos/Familias Unidades Empezando Retos y Tareas para el Éxito [CLS-FUERTE]:) will be…
- Trial name
- CLS-FUERTE (NCT02888821)
- Testing
- CLS-FUERTE
- Volunteers
- 58 people
- Sponsor
- University of California, San Francisco
Attention-deficit/Hyperactivity Disorder
Executive Functioning and Mindfulness in Adults With Attention Deficit/Hyperactivity Disorder Imaging
The main purpose of this study is to evaluate changes in brain functioning using an MRI machine following mindfulness meditation training.
- Trial name
- EFMImaging (NCT01629914)
- Testing
- Mindfulness Meditation
- Volunteers
- healthy volunteers welcome
- Sponsor
- Duke University
Attention Deficit Hyperactivity Disorder
Virtual Reality in Rehabilitation of Executive Functions in Children With Attention Deficit Hyperactivity Disorder.
Attention deficit hyperactivity disorder (ADHD) is caused by an abnormality in the development of the central nervous system. Children with attention and executive function difficulties often need long-lasting rehabilitation and…
- Trial name
- VREALFUN-ADHD (NCT06123741)
- Testing
- Parental Guidance, Virtual Reality Game
- Where
- Finland
- Volunteers
- 88 people
- Sponsor
- Merja Nikula
Conduct Disorder
Trial of Aripiprazole in the Treatment of CD in Adolescents
The proposed study will be a 6-week open label study evaluating aripiprazole in the treatment of 12 male post-pubertal adolescents (13-17 years, Tanner Stage 4) diagnosed with conduct disorder.
- Trial name
- NCT00250705
- Testing
- Aripiprazole
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- University of Iowa
Attention Deficit Disorder With Hyperactivity
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD).
- Trial name
- NCT00050622
- Testing
- Methylphenidate 0.15 mg/kg, Low-Intensity BMOD, Methylphenidate 0.3 mg/kg
- Where
- 2 sites in United States
- Volunteers
- 154 people
- Sponsor
- Florida International University
Attention Deficit Hyperactivity Disorder
The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults
The aim of the study is to assess the effect of Methylphenidate on cognitive performance and decision-making ability of ADHD adults, and to compare this effect to the effect on healthy control adults.
- Trial name
- NCT01040702
- Testing
- methylphenidate, sweetener pill
- Where
- Israel
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Shalvata Mental Health Center
Attention Deficit Hyperactivity Disorder
A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD
Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that presents during childhood, with at least some symptoms causing impairment before the age of seven.
- Trial name
- NCT02086864
- Testing
- lactose/sucrose granule (Individualized homeopathic medicine treatment), Homeopathic consultation
- Where
- Canada
- Volunteers
- 151 people
- Sponsor
- University of Toronto
Insomnia Chronic, Oppositional Defiant Disorder
SLEEP-COPE: Sleep Intervention for Oppositional Children
Children with Oppositional Defiant Disorder (ODD) are at risk for insomnia, arousal dysfunction, mood problems, and noncompliance.
- Trial name
- NCT06350292
- Testing
- SLEEP: COPE
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- University of South Florida